Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Yu

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Thrombosis and Haemostasis|October 31, 2020
A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary InterventionYing-Ying Zheng, Ting-Ting Wu, Ying Gao, et al.
Zhonghua Yi Xue Za Zhi|February 16, 2012
[Cross-sectional study of current situation of glycemic control with type 1 diabetes in Guangdong Province]Hong-rong Deng, Ge Wu, Guo-chun Luo, et al.
Nature Communications|July 7, 2021
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in WuhanCesheng Li, Ding Yu, Xiao Wu, et al.
JAMA Oncology|February 8, 2024
Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases: A Randomized, Double-Blind, Phase 3 Equivalence TrialShaohua Zhang, Yongmei Yin, Hailin Xiong, et al.
Journal of Hematology & Oncology|April 18, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Yongping Song, Yan Qin, et al.
Journal of Personality|October 22, 2024
Personal Relative Deprivation and Locus of ControlMitchell J Callan, Robbie M Sutton, Phatthanakit Chobthamkit, et al.
Journal for Immunotherapy of Cancer|October 25, 2024
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trialZhiming Li, Wenqi Jiang, Hui Zhou, et al.
Cell Discovery|December 9, 2022
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in WuhanHong Liang, Xuanxuan Nian, Junzheng Wu, et al.
Cell Research|June 17, 2021
A cohort autopsy study defines COVID-19 systemic pathogenesisXiao-Hong Yao, Tao Luo, Yu Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2020
Effectiveness of convalescent plasma therapy in severe COVID-19 patientsKai Duan, Bende Liu, Cesheng Li, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Thrombosis and Haemostasis|October 31, 2020
A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary InterventionYing-Ying Zheng, Ting-Ting Wu, Ying Gao, et al.
Zhonghua Yi Xue Za Zhi|February 16, 2012
[Cross-sectional study of current situation of glycemic control with type 1 diabetes in Guangdong Province]Hong-rong Deng, Ge Wu, Guo-chun Luo, et al.
Nature Communications|July 7, 2021
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in WuhanCesheng Li, Ding Yu, Xiao Wu, et al.
JAMA Oncology|February 8, 2024
Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases: A Randomized, Double-Blind, Phase 3 Equivalence TrialShaohua Zhang, Yongmei Yin, Hailin Xiong, et al.
Journal of Hematology & Oncology|April 18, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Yongping Song, Yan Qin, et al.
Journal of Personality|October 22, 2024
Personal Relative Deprivation and Locus of ControlMitchell J Callan, Robbie M Sutton, Phatthanakit Chobthamkit, et al.
Journal for Immunotherapy of Cancer|October 25, 2024
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trialZhiming Li, Wenqi Jiang, Hui Zhou, et al.
Cell Discovery|December 9, 2022
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in WuhanHong Liang, Xuanxuan Nian, Junzheng Wu, et al.
Cell Research|June 17, 2021
A cohort autopsy study defines COVID-19 systemic pathogenesisXiao-Hong Yao, Tao Luo, Yu Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2020
Effectiveness of convalescent plasma therapy in severe COVID-19 patientsKai Duan, Bende Liu, Cesheng Li, et al.
Pageof 32